Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Long-Term Follow-up Study of SAT-3247 in Patients With Duchenne Muscular Dystrophy (DMD) Including Those Who Participated in SAT-3247-CL-101

NCT06867107 is registered in ClinicalTrials.gov with Satellos Bioscience, Inc. as lead sponsor.

NCT NCT06867107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06867107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Long-Term Follow-up Study of SAT-3247 in Patients With Duchenne Muscular Dystrophy (DMD) Including Those Who Participated in SAT-3247-CL-101
Lead sponsor
Satellos Bioscience, Inc.
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
August 20, 2025
Completion date
September 30, 2027
Enrollment
30 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy (dmd)